Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia
Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia
复制标题
DOI：
10.1016/j.japh.2016.12.070
复制
发表时间：
2017-03-01
影响因子：
2.1
通讯作者：
Dwibedi, Nilanjana
中科院分区：
文献类型：
--
作者：
Thornton, J. Douglas;Lyvers, Elizabeth;Dwibedi, Nilanjana
目的：本研究的目的是评估西弗吉尼亚州药剂师对阿片类药物相关药物的库存和配药实践，并确定与在社区药房提供纳洛酮相关的教育需求。设计：创建并验证了一项横断面、匿名、49 项调查，以评估西弗吉尼亚州社区药剂师的教育需求。地点：西弗吉尼亚州。参与者：数据收集工具对目前在西弗吉尼亚州获得许可的 266 名药剂师进行管理。 2016 年 3 月 1 日至 6 月 15 日，在全州开展了 6 场继续药学教育活动。 结果衡量：药剂师的教育需求是使用扩展并行过程模型确定的，该模型有 4 个主要结构：感知严重性、感知易感性、反应功效和自我效能。药剂师对阿片类药物及相关药物的库存和分配情况也进行了评估。结果：药剂师完成了 157 项调查。他们以男性（56.1%）为主，全职员工（67.5%），主要在社区药房工作（69.4%），平均年龄为50.19岁（SD = 13.62）。新采用的阿片类药物感知功效和阿片类药物不良事件感知严重程度量表的可靠性和有效性进行了测试。接受调查的社区药剂师中，只有 20.4% 的人愿意在没有处方的情况下销售纳洛酮。至于其他阿片类药物相关药物，只有 53.3% 储存丁丙诺啡，74.8% 储存丁丙诺啡/纳洛酮。 结论：作为最容易获得的医疗保健提供者，社区药剂师敏锐地意识到阿片类药物流行病如何影响其社区。西弗吉尼亚州的一些药剂师对于储存和分发阿片类药物和阿片类药物依赖药物犹豫不决。尽管这可能会减少潜在滥用药物进入社区的流量，但也可能限制阿片类药物使用障碍患者获得必要的治疗。此外，西弗吉尼亚州的药剂师还不太愿意储存和分配纳洛酮。量身定制的教育材料可以帮助控制药剂师的恐惧并强化非处方纳洛酮使用的好处。 (C) 2017 年美国药剂师协会 (R)。由爱思唯尔公司出版。保留所有权利。
Objectives: The objective of this study is to assess West Virginia pharmacists' stocking and dispensing practices of opioid-related medications and to identify the educational needs relating to providing naloxone in community pharmacies.Design: A cross-sectional, anonymous, 49-item survey was created and validated to assess the educational needs of West Virginia community pharmacists.Setting: West Virginia.Participants: The data collection instrument was administered to 266 pharmacists currently licensed in West Virginia at 6 continuing pharmacy education events throughout the state from March 1 to June 15, 2016.Outcome measures: Pharmacists' educational needs were determined using the Extended Parallel Process Model, which has 4 main constructs: perceived severity, perceived susceptibility, response efficacy, and self-efficacy. Pharmacists' stocking and dispensing of opioids and related medications were also assessed.Results: Pharmacists completed 157 surveys. They were mostly male (56.1%), full-time employees (67.5%), worked mostly in community pharmacies (69.4%), and had a mean age of 50.19 years (SD = 13.62). The newly adapted opioid perceived efficacy and perceived severity of opioid adverse events scales were tested for reliability and validity. Only 20.4% of the community pharmacists surveyed felt comfortable selling naloxone without a prescription. As for the other opioid-related medications, only 53.3% stocked buprenorphine and 74.8% stocked buprenorphine/naloxone.Conclusions: As the most accessible health care providers, community pharmacists are acutely aware of how the opioid epidemic affects their communities. Some pharmacists in West Virginia are hesitant to stock and dispense opioids and opioid-dependence medications. Although this may decrease the flow of potentially abused drugs into the community, it may also restrict access to necessary therapy for patients with opioid use disorder. Furthermore, pharmacists in West Virginia are not yet comfortable stocking and dispensing naloxone. Tailored educational materials can help in controlling the pharmacists' fear and reinforce the benefits of over-the-counter naloxone use. (C) 2017 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.